Surveillance cultures following a regional outbreak of carbapenem-resistant


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
04 2022
Historique:
pubmed: 15 5 2021
medline: 23 4 2022
entrez: 14 5 2021
Statut: ppublish

Résumé

The primary aim of this study was to assess the epidemiology of carbapenem-resistant Acinetobacter baumannii (CRAB) for 9 months following a regional outbreak with this organism. We also aimed to determine the differential positivity rate from different body sites and characterize the longitudinal changes of surveillance test results among CRAB patients. Observational study. A 607-bed tertiary-care teaching hospital in Milwaukee, Wisconsin. Any patient admitted from postacute care facilities and any patient housed in the same inpatient unit as a positive CRAB patient. Participants underwent CRAB surveillance cultures from tracheostomy secretions, skin, and stool from December 5, 2018, to September 6, 2019. Cultures were performed using a validated, qualitative culture method, and final bacterial identification was performed using mass spectrometry. In total, 682 patients were tested for CRAB, of whom 16 (2.3%) were positive. Of the 16 CRAB-positive patients, 14 (87.5%) were residents from postacute care facilities and 11 (68.8%) were African American. Among positive patients, the positivity rates by body site were 38% (6 of 16) for tracheal aspirations, 56% (9 of 16) for skin, and 82% (13 of 16) for stool. Residents from postacute care facilities were more frequently colonized by CRAB than patients admitted from home. Stool had the highest yield for identification of CRAB.

Identifiants

pubmed: 33985611
pii: S0899823X21001628
doi: 10.1017/ice.2021.162
doi:

Substances chimiques

Anti-Bacterial Agents 0
Carbapenems 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

454-460

Auteurs

Frida Rivera (F)

Division of Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

Allison Reeme (A)

Department of Infection Prevention and Control, Froedtert Hospital, Milwaukee, Wisconsin.

Mary Beth Graham (MB)

Division of Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

Blake W Buchan (BW)

Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Nathan A Ledeboer (NA)

Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Ann M Valley (AM)

Wisconsin State Laboratory of Hygiene, Madison, Wisconsin.

L Silvia Munoz-Price (LS)

Division of Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH